Extending our knowledge of immune cell subpopulations, their functional states, and the roles that these cells play in dormancy, recurrence, and treatment susceptibility of ER+ metastatic disease in different locations, is a critical area of need. This evidence concerns the gene ESR1 and metastatic neoplasm.